LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
Chinese Science Academy Chief urges seizing on new technological revolution
Mr. Bai Chunli, president of the Chinese Academy of Sciences (CAS), said during an interview with Xinhua news agancy that while facing the new round of science and technology revolution, developed countries and emerging ones stand at the same starting line.

China, as a developing country, should make good use of global innovation resources and draw on the good practices of developed countries in order to avoid detours and catch up with those countries that are currently leaders in technology, Mr. Bai said.

He also urged strategic planning at the national level to raise science and technology to a more prominent place, stressing research in basic sciences and pioneering disciplines where revolutionary findings might emerge, including material sciences, life sciences, information sciences and earth sciences.

Furthermore, he said China's capacity for science and technology innovation has improved significantly over the past decade.

He cited several figures, including those showing that China's investment in research and development stood at 861 billion yuan (137.9 billion U.S. dollars) in 2011, making it the second-highest such investment in the world.

Moreover, he said that the country's Science Citation Index (SCI) rose to the seventh place in the world in 2011 and the number of Patent Cooperation Treaty (PCT) applications ranked fourth globally.

Mr. Bai expects that by 2020 China's investment in the science and technology sector will account for 2.5 percent of the country's gross domestic product (GDP). Calculated with the estimated growth rate of the GDP, scientific and technological investment will exceed 2 trillion yuan by then.

Click here for the complete issue.

news Runners' High, Happy Feet — If you're Happy, and you know it 'Clap' your Feet
news Snapshot of Stem Cell Expression using Single-cell RNA Sequencing
news A Heroic Voyage — Sydney Brenner's Life in Science
news VeloX, A Minimally Invasive Prosthetic Heart Valve for treating Mitral Regurgitation
news Anti-CD25 monoclonal antibody (90Y-daclizumab) a favorable target towards systemic radio-immunotherapy in Hodgkin's Lymphoma

Credits to Sony Computer Entertainment and click here for behind the scenes.

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy